Brief: Caribou Biosciences Q4 Licensing And Collaboration Revenue USD 3.941 Million
05/03/2026 21:05
Mar 05 (Reuters) - Caribou Biosciences Q4 basic EPS USD -0.28. Q4 net income USD -26.488 million
CRBU — Caribou Biosciences News Story
0.000.00%
Last trade - 00:00- $57.12m
- -$55.19m
- $11.16m